4.5 Article

Pemphigus foliaceous-like reaction in a patient with chronic myeloid leukemia treated with the tyrosine kinase inhibitors nilotinib and dasatinib

Journal

INTERNATIONAL JOURNAL OF DERMATOLOGY
Volume 53, Issue 4, Pages 494-496

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1365-4632.2012.5728.x

Keywords

-

Categories

Funding

  1. Abbott
  2. Amgen
  3. Wyeth
  4. Astellas
  5. Centocor
  6. Genentech
  7. Stiefel
  8. Eisai
  9. Pfizer
  10. Celgene
  11. Merck
  12. Novartis

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available